Resources

Resources

Lessons Learned from a Non-linear Product Launch

The first year post-launch is often the most critical time in determining the long-term commercial success of a drug. If a product launches despite a rocky start, there is still time to maximize drug adoption and realize the ultimate value from a new product launch.

In this case study, we profile a life sciences manufacturer looking for a partner to help them navigate their market access challenges realized during launch. Their need for automation, audit-readiness, data-driven decision making, and the need for partnership lead them to IntegriChain and the ICyte platform as the foundation to achieve their vision for market access success.

Download now!

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand